If Genzyme is in play, the top biotech analyst on the Street thinks the stock could go to $80.
As you might remember, a flurry of reports hit the Street last week suggesting drug giant Sanofi-Aventis was sounding out Genzyme in a hunt for a large acquisition.
But we know that speculation is more often wrong that it's right. So for insights we turned to the Street’s #1 ranked analyst -- ISI analyst Dr. Mark Schoenebaum. He tells the desk, "It actually makes sense!"
Here's why.
Genzyme is run by its founding CEO. He’s been CEO for 25 years. He’s 66 years old. Also the company has been having manufacturing problems and there are activists on the board.
"I’m not sure he needs that kind of pain in the neck," says Schoenebaum. "In my mind it gives the CEO a graceful exit."
But is an announcement imminent? Well, that all depends on your timeframe.
"I think we’re months away not days or weeks, but I think it’s likely to happen," Schoenebaum says.
Find out what Schoenebaum says about other stocks in this space. Watch the video now!
______________________________________________________
Got something to to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send those e-mails to .
Trader disclosure: On July 27, 2010, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders: Adami owns (AGU), (BTU), (NUE), (C), (GS), (INTC), (MSFT); Adami’s wife works at Merck; Grasso owns (ASTM), (ABK), (BAC), (BA), (BGP), (C), (CSCO), (DYN), (JPM), (LPX), (MO), (NDAQ), (PFE), (PRST); Kelly owns (BP) puts; Jon Najarian owns (AAPL) call spreads; Jon Najarian is long and short (BIIB) calls; Jon Najarian is long and short (MSFT) calls; Jon Najarian owns (SNDK) and is short calls; Terranova owns (AMZN), (EMC), (CREE), (BRCM), (LRCX), (COP), (AXP), (BMO), (CSX), (PEP), (CVS), (GS), (PCP), (C), (APA), (FCX), (JOYG), (MMM), (MOS), (UAUA), (WYNN), (GOOG), (BBY), (SU), (KOL), (XBI), (SWN), (BAX), (JNPR); Terranova is short (GLD)
For Steve Grasso:
Stuart Frankel & Co and it’s partners own (BAX)
Stuart Frankel & Co and it’s partners own (COG)
Stuart Frankel & Co and it’s partners own (CUBA)
Stuart Frankel & Co and it’s partners own (DHR)
Stuart Frankel & Co and it’s partners own (DYN)
Stuart Frankel & Co and it’s partners own (GERN)
Stuart Frankel & Co and it’s partners own (HSPO)
Stuart Frankel & Co and it’s partners own (IP)
Stuart Frankel & Co and it’s partners own (MERC)
Stuart Frankel & Co and it’s partners own (NWS.A)
Stuart Frankel & Co and it’s partners own (NYX)
Stuart Frankel & Co and it’s partners own (PDE)
Stuart Frankel & Co and it’s partners own (PFE)
Stuart Frankel & Co and it’s partners own (PRST)
Stuart Frankel & Co and it’s partners own (RDC)
Stuart Frankel & Co and it’s partners own (SYMC)
Stuart Frankel & Co and it’s partners own (TBT)
Stuart Frankel & Co and it’s partners own (TLM)
Stuart Frankel & Co and it’s partners own (TRV)
Stuart Frankel & Co and it’s partners own (XRX)
Stuart Frankel & Co and it’s partners own (SDS)
Stuart Frankel & Co and it’s partners are short (QQQQ)
For Joe Terranova
Terranova works for (VRTS)
Terranova is chief market strategist of Virtus Investment Partners, LTD.
Virtus Investment Partners owns more than 1% of (CASS)
Virtus Investment Partners owns more than 1% of (LDR)
Virtus Investment Partners owns more than 1% of (LPHI)
Virtus Investment Partners owns more than 1% of (MGRC)
Virtus Investment Partners owns more than 1% of (XLB)
Virtus Investment Partners owns more than 1% of (XLP)
Virtus Investment Partners owns more than 1% of (XLY)
Virtus Investment Partners owns more than 1% of (XLI)
Virtus Investment Partners owns more than 1% of (XLK)
Virtus Investment Partners owns more than 1% of (XLU)
Virtus Investment Partners owns more than 1% of (SUBK)
Virtus Investment Partners owns more than 1% of (WDFC)
Virtus Investment Partners owns more than 1% of (YDNT)
Virtus Investment Partners owns more than 1% of (DRYS)
For Brian Kelly
Accounts managed by Kanundrum Capital own (UNG)
Accounts managed by Kanundrum Capital own (BAK)
Accounts managed by Kanundrum Capital own (ORI)
Accounts managed by Kanundrum Capital own (VIV)
Accounts managed by Kanundrum Capital own (XLF)
Accounts managed by Kanundrum Capital own (GME)
Accounts managed by Kanundrum Capital own (OIH)
Accounts managed by Kanundrum Capital owns Euros
Accounts managed by Kanundrum Capital owns Australian Dollars
Accounts managed by Kanundrum Capital own (TBT)
Accounts managed by Kanundrum Capital own (AAPL) calls
Accounts managed by Kanundrum Capital are short (GLD)
Accounts managed by Kanundrum Capital are short the Yen
Accounts managed by Kanundrum Capital are short the US Dollars
For Paul Sankey
(XOM), (COP), (CVX), (VLO) is an investment banking client of Deutsche Bank
Deutsche Bank received non-investment banking compensation from (XOM), (COP), (CVX), (OXY) (VLO) in the past year.
Deutsche Bank provided non-investment banking securities related services to (XOM), (COP), (CVX), (OXY) (VLO) in the past year.
Deutsche Bank owns 1% or more of (VLO), (COP) of any class of common equity securities.
For Dr. Mark Schoenebaum
ISI seeks to do business with (AMGN), (GILD), (GENZ), (BIIB), (VRTX), (HGSI), (UTHR), (AMLN), (ACOR) and has received non-investment banking compensation in the past 12 months.
For Colin McGranahan:
Colin McGranahan maintains long positions in Kohl's Corp. (KSS), Amazon (AMZN), Ross Stores Inc. (ROST), Safeway Inc. (SWY) and Gap Inc. (GPS)
Bernstein or an affiliate expects to receive or intends to seek compensation for investment banking services from BBY
Scott Nations
***No Disclosures***
CNBC.com with wires